US Stock MarketDetailed Quotes

Puma Biotechnology (PBYI)

Watchlist
  • 5.880
  • -0.120-2.00%
Close Mar 12 16:00 ET
  • 5.880
  • 0.0000.00%
Post 16:11 ET
299.15MMarket Cap9.64P/E (TTM)

Puma Biotechnology (PBYI) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
7.41%41.8M
-7.61%14.42M
-12.22%9.69M
1,271.18%14.08M
-67.88%3.61M
44.09%38.92M
49.28%15.61M
3.98%11.04M
-68.84%1.03M
325.50%11.25M
Net income from continuing operations
2.75%31.11M
-30.39%13.44M
-56.47%8.84M
229.28%5.86M
161.77%2.97M
40.23%30.28M
57.36%19.31M
250.53%20.32M
-313.03%-4.53M
-443.68%-4.82M
Operating gains losses
--4K
--0
----
----
----
----
----
----
----
----
Depreciation and amortization
-5.09%10.94M
-6.48%2.66M
-5.42%2.72M
-4.99%2.76M
-3.49%2.8M
0.04%11.52M
-1.66%2.84M
0.07%2.88M
1.11%2.91M
0.66%2.9M
Deferred tax
145.87%3.25M
----
----
----
----
---7.08M
----
----
----
----
Change In working capital
-185.09%-10.08M
-699.27%-6.54M
76.41%-3.34M
445.90%4.2M
-141.18%-4.4M
80.20%-3.54M
89.09%-818K
-1,054.28%-14.16M
116.53%769K
338.65%10.68M
-Change in receivables
-230.20%-21.28M
-187.23%-20.09M
71.91%-7.44M
88.74%-376K
-71.37%6.63M
295.33%16.35M
219.76%23.03M
-1,243.78%-26.49M
-421.56%-3.34M
151.94%23.14M
-Change in inventory
295.19%3.21M
165.46%3.96M
-113.88%-885K
108.21%160K
-35.00%-27K
35.63%-1.64M
-331.91%-6.05M
226.64%6.38M
47.89%-1.95M
-103.15%-20K
-Change in prepaid assets
-132.50%-325K
48.05%-718K
-108.37%-84K
30.79%1.27M
-291.97%-789K
21.95%1M
-147.23%-1.38M
34.27%1M
506.72%968K
-52.76%411K
-Change in payables and accrued expense
173.83%12.7M
173.24%11.55M
10.13%6.24M
-26.51%4.28M
27.57%-9.37M
-141.14%-17.2M
-219.81%-15.76M
232.23%5.67M
789.31%5.83M
22.40%-12.93M
-Change in other current assets
-120.10%-165K
-117.93%-26K
-3,240.00%-157K
78.57%25K
-101.07%-7K
-45.88%821K
-86.52%145K
100.35%5K
111.29%14K
-66.82%657K
-Change in other current liabilities
-90.37%-2.41M
-80.16%-672K
-115.53%-666K
-91.45%-672K
-71.79%-402K
-34.79%-1.27M
-83.74%-373K
-33.19%-309K
-29.04%-351K
-0.43%-234K
-Change in other working capital
-13.74%-1.81M
-27.42%-539K
16.18%-347K
-21.50%-486K
-23.71%-433K
-32.80%-1.59M
-23.68%-423K
-33.55%-414K
-36.52%-400K
-40.00%-350K
Cash from discontinued investing activities
Operating cash flow
7.41%41.8M
-7.61%14.42M
-12.22%9.69M
1,271.18%14.08M
-67.88%3.61M
44.09%38.92M
49.28%15.61M
3.98%11.04M
-68.84%1.03M
325.50%11.25M
Investing cash flow
Cash flow from continuing investing activities
-77.06%-36.19M
-1,062.80%-26.98M
95.37%506K
-1,700.00%-11.25M
108.02%1.53M
-6.87%-20.44M
71.60%-2.32M
-97.68%259K
115.01%703K
-9.34%-19.08M
Net PPE purchase and sale
-26.79%-71K
325.00%36K
-30.00%-26K
0.00%-20K
---61K
60.00%-56K
64.44%-16K
25.93%-20K
---20K
--0
Net intangibles purchase and sale
--0
----
----
----
----
--0
--0
--0
--0
--0
Net investment purchase and sale
-77.20%-36.12M
-1,072.44%-27.01M
90.68%532K
-1,652.97%-11.23M
108.34%1.59M
-214.29%-20.38M
71.64%-2.3M
-97.51%279K
115.67%723K
-285.45%-19.08M
Cash from discontinued investing activities
Investing cash flow
-77.06%-36.19M
-1,062.80%-26.98M
95.37%506K
-1,700.00%-11.25M
108.02%1.53M
-6.87%-20.44M
71.60%-2.32M
-97.68%259K
115.01%703K
-9.34%-19.08M
Financing cash flow
Cash flow from continuing financing activities
-33.54%-45.2M
-0.01%-11.33M
-1.33%-11.33M
1.15%-11.2M
-11.33M
-33.85M
-11.33M
-11.18M
-11.33M
0
Net issuance payments of debt
-33.33%-44.44M
0.00%-11.11M
0.00%-11.11M
0.00%-11.11M
---11.11M
---33.33M
---11.11M
---11.11M
---11.11M
--0
Net common stock issuance
----
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
-13.33%130K
--0
--0
----
----
--150K
--0
--150K
----
----
Net other financing activities
-33.33%-888K
-0.45%-222K
0.45%-222K
---222K
---222K
---666K
---221K
---223K
----
----
Cash from discontinued financing activities
Financing cash flow
-33.54%-45.2M
-0.01%-11.33M
-1.33%-11.33M
1.15%-11.2M
---11.33M
---33.85M
---11.33M
---11.18M
---11.33M
--0
Net cash flow
Beginning cash position
-17.73%71.31M
-19.81%55.62M
-18.03%56.75M
-17.40%65.12M
-17.73%71.31M
10.01%86.68M
-17.82%69.35M
10.61%69.24M
23.22%78.84M
10.01%86.68M
Current changes in cash
-157.61%-39.58M
-1,321.37%-23.89M
-1,097.37%-1.14M
12.85%-8.37M
21.00%-6.19M
-294.90%-15.37M
-14.40%1.96M
-99.48%114K
-592.29%-9.6M
47.09%-7.83M
End cash Position
-55.51%31.73M
-55.51%31.73M
-19.81%55.62M
-18.03%56.75M
-17.40%65.12M
-17.73%71.31M
-17.73%71.31M
-17.82%69.35M
10.61%69.24M
23.22%78.84M
Free cash flow
7.38%41.73M
-7.29%14.46M
-12.30%9.66M
1,296.43%14.06M
-68.42%3.55M
170.46%38.86M
49.77%15.59M
4.06%11.02M
-68.80%1.01M
214.09%11.25M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 7.41%41.8M-7.61%14.42M-12.22%9.69M1,271.18%14.08M-67.88%3.61M44.09%38.92M49.28%15.61M3.98%11.04M-68.84%1.03M325.50%11.25M
Net income from continuing operations 2.75%31.11M-30.39%13.44M-56.47%8.84M229.28%5.86M161.77%2.97M40.23%30.28M57.36%19.31M250.53%20.32M-313.03%-4.53M-443.68%-4.82M
Operating gains losses --4K--0--------------------------------
Depreciation and amortization -5.09%10.94M-6.48%2.66M-5.42%2.72M-4.99%2.76M-3.49%2.8M0.04%11.52M-1.66%2.84M0.07%2.88M1.11%2.91M0.66%2.9M
Deferred tax 145.87%3.25M-------------------7.08M----------------
Change In working capital -185.09%-10.08M-699.27%-6.54M76.41%-3.34M445.90%4.2M-141.18%-4.4M80.20%-3.54M89.09%-818K-1,054.28%-14.16M116.53%769K338.65%10.68M
-Change in receivables -230.20%-21.28M-187.23%-20.09M71.91%-7.44M88.74%-376K-71.37%6.63M295.33%16.35M219.76%23.03M-1,243.78%-26.49M-421.56%-3.34M151.94%23.14M
-Change in inventory 295.19%3.21M165.46%3.96M-113.88%-885K108.21%160K-35.00%-27K35.63%-1.64M-331.91%-6.05M226.64%6.38M47.89%-1.95M-103.15%-20K
-Change in prepaid assets -132.50%-325K48.05%-718K-108.37%-84K30.79%1.27M-291.97%-789K21.95%1M-147.23%-1.38M34.27%1M506.72%968K-52.76%411K
-Change in payables and accrued expense 173.83%12.7M173.24%11.55M10.13%6.24M-26.51%4.28M27.57%-9.37M-141.14%-17.2M-219.81%-15.76M232.23%5.67M789.31%5.83M22.40%-12.93M
-Change in other current assets -120.10%-165K-117.93%-26K-3,240.00%-157K78.57%25K-101.07%-7K-45.88%821K-86.52%145K100.35%5K111.29%14K-66.82%657K
-Change in other current liabilities -90.37%-2.41M-80.16%-672K-115.53%-666K-91.45%-672K-71.79%-402K-34.79%-1.27M-83.74%-373K-33.19%-309K-29.04%-351K-0.43%-234K
-Change in other working capital -13.74%-1.81M-27.42%-539K16.18%-347K-21.50%-486K-23.71%-433K-32.80%-1.59M-23.68%-423K-33.55%-414K-36.52%-400K-40.00%-350K
Cash from discontinued investing activities
Operating cash flow 7.41%41.8M-7.61%14.42M-12.22%9.69M1,271.18%14.08M-67.88%3.61M44.09%38.92M49.28%15.61M3.98%11.04M-68.84%1.03M325.50%11.25M
Investing cash flow
Cash flow from continuing investing activities -77.06%-36.19M-1,062.80%-26.98M95.37%506K-1,700.00%-11.25M108.02%1.53M-6.87%-20.44M71.60%-2.32M-97.68%259K115.01%703K-9.34%-19.08M
Net PPE purchase and sale -26.79%-71K325.00%36K-30.00%-26K0.00%-20K---61K60.00%-56K64.44%-16K25.93%-20K---20K--0
Net intangibles purchase and sale --0------------------0--0--0--0--0
Net investment purchase and sale -77.20%-36.12M-1,072.44%-27.01M90.68%532K-1,652.97%-11.23M108.34%1.59M-214.29%-20.38M71.64%-2.3M-97.51%279K115.67%723K-285.45%-19.08M
Cash from discontinued investing activities
Investing cash flow -77.06%-36.19M-1,062.80%-26.98M95.37%506K-1,700.00%-11.25M108.02%1.53M-6.87%-20.44M71.60%-2.32M-97.68%259K115.01%703K-9.34%-19.08M
Financing cash flow
Cash flow from continuing financing activities -33.54%-45.2M-0.01%-11.33M-1.33%-11.33M1.15%-11.2M-11.33M-33.85M-11.33M-11.18M-11.33M0
Net issuance payments of debt -33.33%-44.44M0.00%-11.11M0.00%-11.11M0.00%-11.11M---11.11M---33.33M---11.11M---11.11M---11.11M--0
Net common stock issuance ----------------------0----------------
Proceeds from stock option exercised by employees -13.33%130K--0--0----------150K--0--150K--------
Net other financing activities -33.33%-888K-0.45%-222K0.45%-222K---222K---222K---666K---221K---223K--------
Cash from discontinued financing activities
Financing cash flow -33.54%-45.2M-0.01%-11.33M-1.33%-11.33M1.15%-11.2M---11.33M---33.85M---11.33M---11.18M---11.33M--0
Net cash flow
Beginning cash position -17.73%71.31M-19.81%55.62M-18.03%56.75M-17.40%65.12M-17.73%71.31M10.01%86.68M-17.82%69.35M10.61%69.24M23.22%78.84M10.01%86.68M
Current changes in cash -157.61%-39.58M-1,321.37%-23.89M-1,097.37%-1.14M12.85%-8.37M21.00%-6.19M-294.90%-15.37M-14.40%1.96M-99.48%114K-592.29%-9.6M47.09%-7.83M
End cash Position -55.51%31.73M-55.51%31.73M-19.81%55.62M-18.03%56.75M-17.40%65.12M-17.73%71.31M-17.73%71.31M-17.82%69.35M10.61%69.24M23.22%78.84M
Free cash flow 7.38%41.73M-7.29%14.46M-12.30%9.66M1,296.43%14.06M-68.42%3.55M170.46%38.86M49.77%15.59M4.06%11.02M-68.80%1.01M214.09%11.25M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to disrupt the stock market. On March 11 local time, Trump once again s Show More